Perrigo (NASDAQ: PRGO) posted its quarterly earnings results on Tuesday. The company reported $1.42 earnings per share (EPS) for the quarter, missing the consensus estimate of $1.44 by $0.02, AnalystRatings.Net reports. The company had revenue of $919.83 million for the quarter, compared to the consensus estimate of $935.44 million. During the same quarter in the previous year, the company posted $1.41 earnings per share. The company’s revenue for the quarter was up 18.2% on a year-over-year basis. Perrigo updated its FY13 guidance to $5.53-5.73 EPS.

Several analysts have also recently commented on the stock. Analysts at RBC Capital raised their price target on shares of Perrigo from $111.00 to $121.00 in a research note to investors on Monday. They now have a “sector perform” rating on the stock. On the ratings front, analysts at Leerink Swann initiated coverage on shares of Perrigo in a research note to investors on Wednesday, April 24th. They set a “market perform” rating on the stock. Finally, analysts at JP Morgan Cazenove upgraded shares of Perrigo from a “neutral” rating to an “overweight” rating in a research note to investors on Monday, April 22nd. They now have a $132.00 price target on the stock, up previously from $120.00.

Two research analysts have rated the stock with a sell rating, six have assigned a hold rating and ten have given a buy rating to the company’s stock. Perrigo currently has an average rating of “Hold” and a consensus price target of $125.93.

Shares of Perrigo (NASDAQ: PRGO) opened at 118.84 on Tuesday. Perrigo has a 52 week low of $96.52 and a 52 week high of $121.12. The stock’s 50-day moving average is currently $117.9. The company has a market cap of $11.169 billion and a P/E ratio of 25.28.

The company also recently announced a quarterly dividend, which is scheduled for Tuesday, June 18th. Investors of record on Friday, May 31st will be paid a dividend of $0.09 per share. This represents a $0.36 annualized dividend and a dividend yield of 0.30%. The ex-dividend date is Wednesday, May 29th.

Perrigo Company is a global healthcare supplier that develops, manufactures and distributes over-the-counter (NASDAQ: PRGO) and generic prescription (Rx) pharmaceuticals, infant formulas, nutritional products and active pharmaceutical ingredients (API).

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.